DAVIDSON KEMPNER CAPITAL MANAGEMENT LLC

Q4 2013 13F Holdings Report, Stock Holdings

Signature - Title
Richard D. Chase - Chief Financial Officer
Location
New York, NY
Holdings as of
31 Dec 2013
Value $
$2,505,522,000
Num holdings
105
Filing time
14 Feb 2014, 13:06:25 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included LIFE, GILEAD SCIENCES INC, PRGO, HCBK, and HMA. Confidential Treatment Requested (one or more holding(s) omitted).
Next filing
Q1 2014 - 15 May 2014
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Richard D. Chase Chief Financial Officer New York, New York 14 Feb 2014

Effective January 1, 2014, Davidson Kempner Capital Management LLC (?DKCM LLC?) and Davidson Kempner International Advisors, L.L.C. (?DKIA?) merged and became Davidson Kempner Capital Management LP (?DKCM LP?), which assumed all of the rights and obligations of DKCM LLC and DKIA, including duties as the SEC-registered investment adviser. As a result of the merger, a Form 13F will be filed for the surviving entity, DKCM LP, beginning for the quarter ending March 31, 2014. Form 13F will continue to be filed for DKCM LLC for 1Q14, 2Q14 and 3Q14 as required, but reflecting no 13F securities (since those 13F securities will be reported on DKCM LP's Form 13F beginning March 31, 2014).